Company news
Sun Pharmaceutical Industries Limited news in 2022
Sun Pharmaceutical Industries Limited's news releases, calls and decks from 2022, newest first.
Sun Pharmaceutical Industries Limited - SEZABY approved by US FDA for the treatment of neonatal seizures
November 21, 2022
Press Release Nov 18 2022
November 18, 2022
Press Release Nov 09 2022
November 9, 2022
Press Release Nov 01 2022
November 1, 2022
Press Release Oct 11 2022
October 11, 2022
Press Release Aug 03 2022
August 3, 2022
Press Release Jul 29 2022
July 29, 2022
Press Release Jul 26 2022
July 26, 2022
Press Release May 30 2022
May 30, 2022
Press Release May 27 2022
May 27, 2022
Press Release May 18 2022
May 18, 2022
Press Release May 16 2022
May 16, 2022
Press Release May 12 2022
May 12, 2022
Press Release Mar 30 2022
March 30, 2022
Press Release Mar 25 2022
March 25, 2022
Press Release Jan 31 2022
January 31, 2022
Sun Pharma launches PrCEQUA, the first dry eye treatment with nanomicellar technology, in Canada
January 28, 2022
Press Release Jan 27 2022
January 27, 2022
Sun Pharmaceutical Industries: Dividend Updates
January 25, 2022
Press Release Jan 18 2022
January 18, 2022
Decks in 2022
- Investor Presentation (December 2022)
Investor deck · 54 slides · December 2022
- Investor Presentation (September 2022)
Investor deck · 56 slides · Sep 16, 2022
- Investor Presentation (September 2022)
Investor deck · 55 slides · September 2022
- Investor Presentation (March 2022)
Investor deck · 55 slides · March 2022